MedTrace Logo

Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials

NCT00789789 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 488

Last updated 2017-06-01

No results posted yet for this study

Summary

This cohort study should provide an exhaustive overview on long-term safety of various preventive HIV-vaccines administered in phase I and II clinical trials to healthy volunteers of the ANRS network.

Conditions

  • HIV Infection
  • HIV Seronegativity

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Odile LAUNAY, MD, PhD · CIC Cochin Pasteur, Hôpital Cochin, Paris, France

  • Laurence MEYER, MD, PhD · INSERM SC-10-US019, Villejuif, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00789789 on ClinicalTrials.gov